Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
- PMID: 12820960
- DOI: 10.1016/s1097-2765(03)00220-x
Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
Abstract
Tumor suppressor genes evolved as negative effectors of mitogen and nutrient signaling pathways, such that mutations in these genes can lead to pathological states of growth. Tuberous sclerosis (TSC) is a potentially devastating disease associated with mutations in two tumor suppressor genes, TSC1 and 2, that function as a complex to suppress signaling in the mTOR/S6K/4E-BP pathway. However, the inhibitory target of TSC1/2 and the mechanism by which it acts are unknown. Here we provide evidence that TSC1/2 is a GAP for the small GTPase Rheb and that insulin-mediated Rheb activation is PI3K dependent. Moreover, Rheb overexpression induces S6K1 phosphorylation and inhibits PKB phosphorylation, as do loss-of-function mutations in TSC1/2, but contrary to earlier reports Rheb has no effect on MAPK phosphorylation. Finally, coexpression of a human TSC2 cDNA harboring a disease-associated point mutation in the GAP domain, failed to stimulate Rheb GTPase activity or block Rheb activation of S6K1.
Similar articles
-
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.Curr Biol. 2003 Aug 5;13(15):1259-68. doi: 10.1016/s0960-9822(03)00506-2. Curr Biol. 2003. PMID: 12906785
-
Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity.Mol Cell Biol. 2004 Sep;24(18):7965-75. doi: 10.1128/MCB.24.18.7965-7975.2004. Mol Cell Biol. 2004. PMID: 15340059 Free PMC article.
-
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.Curr Biol. 2004 Sep 21;14(18):1650-6. doi: 10.1016/j.cub.2004.08.026. Curr Biol. 2004. PMID: 15380067
-
Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis.Cancer Biol Ther. 2003 Sep-Oct;2(5):471-6. doi: 10.4161/cbt.2.5.446. Cancer Biol Ther. 2003. PMID: 14614311 Review.
-
The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.Novartis Found Symp. 2004;262:148-54; discussion 154-9, 265-8. Novartis Found Symp. 2004. PMID: 15562827 Review.
Cited by
-
Regulation of TSC2 lysosome translocation and mitochondrial turnover by TSC2 acetylation status.Sci Rep. 2024 May 31;14(1):12521. doi: 10.1038/s41598-024-63525-7. Sci Rep. 2024. PMID: 38822085 Free PMC article.
-
Carbonic Anhydrase 2 Deletion Delays the Growth of Kidney Cysts Whereas Foxi1 Deletion Completely Abrogates Cystogenesis in TSC.Int J Mol Sci. 2024 Apr 27;25(9):4772. doi: 10.3390/ijms25094772. Int J Mol Sci. 2024. PMID: 38731991 Free PMC article.
-
SF3B3-regulated mTOR alternative splicing promotes colorectal cancer progression and metastasis.J Exp Clin Cancer Res. 2024 Apr 26;43(1):126. doi: 10.1186/s13046-024-03053-4. J Exp Clin Cancer Res. 2024. PMID: 38671459 Free PMC article.
-
A Case Report of Malignant Perivascular Epithelioid Cell Tumors of the Uterus and Literature Review.Int J Womens Health. 2024 Apr 15;16:619-628. doi: 10.2147/IJWH.S453226. eCollection 2024. Int J Womens Health. 2024. PMID: 38645980 Free PMC article.
-
Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets.Cells. 2024 Feb 27;13(5):409. doi: 10.3390/cells13050409. Cells. 2024. PMID: 38474373 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous